Survival Without Adjuvant Therapy for Low-Risk Endometrial Cancer With Isolated Tumor Cells | Synapse
March 14, 2026
Survival Without Adjuvant Therapy for Low-Risk Endometrial Cancer With Isolated Tumor Cells
Key Points
This research examines the effect of adjuvant therapy on survival rates in low-risk endometrial cancer patients.
Cohort study design
Analysis of overall survival rates
Focus on patients with isolated tumor cells in lymph nodes
Patients demonstrated varying survival outcomes without adjuvant therapy
Isolated tumor cells influenced treatment approaches in low-risk cases
Abstract
This cohort study assesses overall survival without adjuvant therapy in patients with uterine factor–based low-risk endometrial cancer who had isolated tumor cells present in regional lymph nodes.